Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2025

Commentary

Presenter: Michael J. Reardon

October 27, 2025

Presentation TCT 2025

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

Presenter: David Daniels

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Tsuyoshi Kaneko

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Stefan Blankenberg

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Bernard Prendergast

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2024

New England Journal of Medicine RCT: DanGer Shock: Operationalizing the Data

Presenter: Babar Basir

October 28, 2024

Presentation TCT 2024

Principal PI Perspectives on the New England Journal of Medicine RCT: DanGer Shock

Presenter: Jacob Moeller

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Presenter: Samir Kapadia

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2022

Transcatheter Aortic Valve Replacement in Small Aortic Annuli: Results From the FRANCE-TAVI Registry

Presenter: Walid Ben-Ali

September 17, 2022

Presentation TCT 2022

Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry

Presenter: Mohamad Alkhouli

September 17, 2022

Advertisement

Commentary

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

Commentary

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Commentary

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Commentary

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

New England Journal of Medicine RCT: DanGer Shock: Operationalizing the Data

Principal PI Perspectives on the New England Journal of Medicine RCT: DanGer Shock

The EARLY TAVR Trial Editorial Commentary

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Four-Year Outcomes From the EVOLUT Low Risk Trial

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Transcatheter Aortic Valve Replacement in Small Aortic Annuli: Results From the FRANCE-TAVI Registry

Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content